drugset / Trial / NCT07471282

Reperfusion Completion Via Local Arterial Infusion of Tenecteplase After Incomplete Mechanical Thrombectomy

NCT07471282

Phase 3 Not yet recruiting 344 enrolled Chuansheng Zhao
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To evaluate the efficacy and safety of intra-arterial TNK bridging therapy following incomplete recanalization (2b ≤ eTICI \< 3) after mechanical thrombectomy for acute anterior circulation large vessel occlusion.

Timeline

Start
2026-03-01
Primary completion
2028-12-31
Completion
2029-03-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tenecteplase Protein / enzyme biologic 0.0938 mg/kg Other

Indications